Commure
PrivateLast Round
VC Round
May 19, 2026
Est. Valuation
$7B
Total Funding Raised
$1B
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Commure is a healthcare technology company that provides an AI-native enterprise platform for health systems, integrating ambient intelligence, agentic AI, and revenue cycle automation to streamline clinical and operational workflows.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, NLP & Conversational AI, Revenue Cycle, EHR & EMR, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Commure Comparables
Compare Commure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ambience Healthcare | 87% | |
| Abridge Inc | 87% | |
| Notable | 82% |
For institutional investors. Book with your work email.
Commure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 19, 2026 | ||||
| Growth Equity | Jun 19, 2025 | ||||
| M&A | Oct 4, 2023 | ||||
| Series D | Sep 16, 2021 | ||||
| Series C | Sep 16, 2021 | ||||
Series B | Apr 26, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Commure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Human Capital | Series D |
| Greenoaks Capital Partners | Series D |
| Lux Capital | Seed |
| Morgan Stanley | VC Round |
| Sequoia Capital | VC Round |
| General Catalyst | Series D, Series C, Seed, M&A, Series A, VC Round, Growth Equity |
| FJ Labs | Seed, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 19, 2026
Utilizing 'OpenClaw agents' for operational workflows.
- Sep 15, 2026
Named to the Fortune Future 50 list.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_awardNov 2, 2026
Commure receives the Silver award for its Orchestrator for Home Health Referral Management.
- attends_eventOct 22, 2026
Commure attends the Abu Dhabi Future Health Summit 2026 in the United Arab Emirates and marks its collaboration with Mediclinic Middle East to advance Ambient AI in clinical care.
- recognized_asOct 20, 2026
Commure's Autonomous Coding achieves Toolbox designation from Epic in the Fully Autonomous Coding category on Epic Showroom in California on Oct 20th '26'.
- partners_withOct 13, 2026
In California on Oct 13th '26, Commure and Compassus announce a strategic partnership to co-develop Commure Orchestrator, an AI-powered referral automation platform now live across 79 programs in 19 states.
- hiresOct 13, 2026
Commure appoints former Qualtrics leader Nick Apeland as President of Go-to-Market to scale agentic AI across health systems’ clinical and financial workflows in California on Oct 7th '26.
For institutional investors. Book with your work email.
Commure Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Appears On
Curated lists and screens where this company is featured.
Frequently Asked Questions
Common questions about Commure's valuation, stock price, and market status.
Is Commure a public or private company?
Commure is a private company.
What is the current stock price of Commure?
Commure is a private company, so its shares have no public market price. Caplight tracks Commure's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Commure worth (valuation)?
Commure's valuation is estimated at $7.0B based on funding round data.
Can I buy Commure stock?
Commure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Commure's last funding round?
Commure's most recent funding round was VC Round on May 19, 2026.
Who are the main investors in Commure?
Key investors in Commure include Human Capital, Greenoaks Capital Partners, General Catalyst.
Will Commure IPO soon?
No public IPO plans have been announced for Commure.
How can I track Commure secondary market activity?
Caplight tracks bids, offers, and trades in Commure's shares on secondary markets.